Who Fares Best With Mindfulness Meditation
2 other identifiers
observational
120
2 countries
3
Brief Summary
The overall aim of this observational study is to investigate how individual differences influence the effects of mindfulness meditation to uncover for whom mindfulness is beneficial and for whom it may be harmful. The first objective is to identify the mechanisms underlying the effects of mindfulness meditation on mental health. The second objective is to examine how three candidate factors, namely trauma symptoms, tendency to dissociate, and repetitive negative thinking, influence the effect of mindfulness meditation on mental health. Adults who enrolled for a Mindfulness-Based Intervention (MBI) at the participating sites (n=120 in total) will be invited to participate. Before the start of the MBI, after half of the sessions, at the end of the MBI and at 3-months follow-up, participants will complete self-report questionnaires. The main outcomes are symptoms of anxiety and depression, quality of life, wellbeing, and adverse effects resulting from the MBI. A subset of participants will be invited for a semi-structured interview after the end of the intervention. Update December 2024: Instead of analysing all subsamples recruited from the different sites separately, the investigators will now analyse all participants from all sites jointly. This amendment has two reasons. First, analysing all participants jointly allows to statistically compare the differences in effects across sites by including a variable that indicates from which site a participant was recruited. If the subsamples are analysed separately, the investigators can only compare the results at face-value but cannot determine whether the effects are statistically different across sites. Second, recruitment could not start at one site because of a restructuring of the mindfulness interventions there and the investigators are experiencing recruitment difficulties in a second site (recruited 5 participants within 1.5 years). Thus, it will not be feasible to recruit 120 participants per site. For those two reasons, the investigators decided to analyse all participants jointly and only recruit 120 participants in total for the quantitative part of this study (see updated study protocol).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2023
CompletedStudy Start
First participant enrolled
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
May 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJanuary 6, 2025
January 1, 2025
2.9 years
January 31, 2023
January 2, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Patient Health Questionnaire-4 (PHQ-4)
The PHQ-4 is a 4-item scale that measures symptoms of depression and anxiety over the last two weeks. Items are scored on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).
Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Change in Recovering Quality of Life (ReQol-10)
The ReQol-10 is a 10-item scale that measures quality of life over the last week. Items are scored on a 5-point Likert scale ranging from 0 (none of the time) to 4 (most or all of the time).
Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Change in Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
The SWEMWBS is a 7-item scale that measures wellbeing over the last two weeks. Items are scored on a 5-point Likert scale ranging from 1 (none of the time) to 5 (all of the time).
Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Change in Meditation-Related Adverse Effects Scale, Mindfulness-Based Program version (MRAES-MBP)
The MRAES-MBP is a 14-item scale that measures mindfulness-related adverse events over the last four weeks. Items are scored on a 5-point Likert scale ranging from 1 (never) to 5 (very often).
Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Secondary Outcomes (7)
Subjective experience of mindfulness practice effects assessed during interview
8 weeks after start of MBI
Change in Comprehensive Inventory of Mindfulness Experiences - Short Form (CHIME-SF)
Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Brief Dissociative Experiences Scale (DES-B)
Before the MBI
Perseverative Thinking Questionnaire (PTQ)
Before the MBI
Modified version of the Life Events Checklist for DSM-5 (LEC-5)
Before the MBI
- +2 more secondary outcomes
Other Outcomes (6)
Previous experience with meditation
Before the MBI
Frequency of mindfulness home practice
4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
Change in Practice Quality-Mindfulness (PQ-M)
4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI
- +3 more other outcomes
Study Arms (2)
Mindfulness centre for general public
Mindfulness course attenders at a mindfulness centre that offers mindfulness trainings for the general public. Participants are thus not selected based on any complaints they may have.
Stress clinic
Mindfulness course attenders at a stress clinic associated with a hospital that offers mindfulness courses for participants with mild complaints, such as stress or worry.
Interventions
All participants will follow a mindfulness course consisting of group sessions of 2-3h duration that are organized (nearly) weekly and are spread over a period of eight weeks. The specific timeline and organisation of the course may differ between the participating sites but all courses will involve a comparable amount of contact hours with the mindfulness trainer. Each session consists of guided experiential mindfulness exercises (e.g., body scan, breathing space, breath focus, walk meditation), sharing of experiences of these exercises, reflections in small groups, psychoeducation, and review of home practices. The mindfulness courses are based on one of the two most well-known MBIs, Mindfulness-Based Cognitive Therapy (Segal et al., 2002) and Mindfulness-Based Stress Reduction (Kabat-Zinn, 1990), or a combination thereof. Courses follow a standardised protocol with group sessions and daily homework tasks taught by experienced and certified mindfulness trainers.
Eligibility Criteria
Adults who enrolled for a Mindfulness-Based Intervention (MBI) at one of the participating study sites.
You may qualify if:
- Enrolled in a mindfulness-based intervention at one of the participating sites
You may not qualify if:
- Insufficient knowledge of the Dutch or English language (depending on the study site)
- No internet access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. dr. Filip Raeslead
- University of Exetercollaborator
Study Sites (3)
ZNA Stresskliniek
Antwerp, Belgium
Mindful Me
Deinze, Belgium
AccEPT clinic
Exeter, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filip Raes, Prof. dr.
KU Leuven
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 31, 2023
First Posted
May 17, 2023
Study Start
February 21, 2023
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
January 6, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- The coded, pseudonymized dataset and supporting information (see above) will be available beginning from 3 months and ending 10 years after publication of the research results.
- Access Criteria
- The receiving party will be bound by contractual agreement to keep the transferred data confidential at all times, to only process the data for the purpose of the Study or for improving scientific knowledge about mindfulness and is not permitted to link the data with other data which might render the information more identifiable. To this end, appropriate Data Transfer Agreements (DTAs) will be established.
Moderately sensitive information including age, demographic data, all other data coming from questionnaires and interview transcripts will be pseudonymized and shared with other researchers upon request. This dataset will only comprise data of those participants who agreed to their data being shared on the consent form.